Multitarget Compounds for Neglected Diseases: A Review

Curr Drug Targets. 2024;25(9):577-601. doi: 10.2174/0113894501298864240627060247.

Abstract

Neglected diseases are a group of infectious diseases, many of them parasitic, that mainly affect the poorest populations with limited access to health services, especially those living in remote rural areas and slums. According to the World Health Organization (WHO), neglected diseases put the lives of more than 200 million people at risk, and treatment is made difficult by the occurrence of resistance to existing medications, as well as the high level of toxicity. In this way, the potential of multitarget compounds is highlighted, defined as compounds designed to modulate multiple targets of relevance to disease, with the overall goal of enhancing efficacy and/or improving safety. Thus, the objective of our study is to evaluate existing multitarget compound approaches for neglected diseases, with an emphasis on Leishmaniasis, Chagas Disease, and Arboviruses. A literature review was performed by searching the database "Web of Sciences". In relation to the diseases covered in this work, Leishmaniasis, individually, was the one that presented the largest number of articles (11) that dealt with the topic, which can be justified by the high prevalence of this disease in the world, the second most common disease was Dengue, followed by Chagas disease, Chikungunya virus, and Zika virus. Furthermore, the multitarget potential of phenolic compounds was observed in all diseases under study, with the mechanisms related to the nucleus and transcription being the most reported mechanisms. From this perspective, it is worth highlighting the effectiveness of approaches related to multitarget drugs in discovering new therapeutic agents for neglected diseases.

Keywords: Medicinal chemistry; biological activity; in silico.; natural products; synthetic compounds; virtual screening.

Publication types

  • Review

MeSH terms

  • Animals
  • Arbovirus Infections / drug therapy
  • Chagas Disease* / drug therapy
  • Humans
  • Leishmaniasis* / drug therapy
  • Molecular Targeted Therapy
  • Neglected Diseases* / drug therapy